Show simple item record

THE EFFECT OF METHIONINE ON THE REGIONAL AND INTRACELLULAR DISPOSITION OF [ 3 H]-METHIONINE SULPHOXIMINE IN RAT BRAIN 1

dc.contributor.authorGhittoni, Nora E.en_US
dc.contributor.authorOhlsson, W. G.en_US
dc.contributor.authorSellinger, Otto Z.en_US
dc.date.accessioned2010-04-01T14:54:07Z
dc.date.available2010-04-01T14:54:07Z
dc.date.issued1970-07en_US
dc.identifier.citationGhittoni, Nora E.; Ohlsson, W. G.; Sellinger, O. Z. (1970). "THE EFFECT OF METHIONINE ON THE REGIONAL AND INTRACELLULAR DISPOSITION OF [ 3 H]-METHIONINE SULPHOXIMINE IN RAT BRAIN 1 ." Journal of Neurochemistry 17(7): 1057-1068. <http://hdl.handle.net/2027.42/65357>en_US
dc.identifier.issn0022-3042en_US
dc.identifier.issn1471-4159en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65357
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5426666&dopt=citationen_US
dc.description.abstract—The intracellular disposition of the convulsant agent, methionine sulphoximine (MSO), administered as methyl-labelled [ 3 H]MSO, was examined in rat brain. Intraperitoneal (i.p.) and intrathecal (i.th.) routes were compared. The effect of simultaneous administration of methionine on the uptake, the regional distribution and the intracellular disposition of [ 3 H]MSO was also assessed: (1) The peak uptake of i.p. [ 3 H]MSO was at 2 h and amounted to about 1 per cent of the dose; the peak uptake of i.th. [ 3 H]MSO was at 30 min post-injection and amounted to 40 per cent of the administered dose. The uptake was effectively reduced when methionine was simultaneously administered. (2) The regional distribution of [ 3 H]MSO as a function of time after injection revealed a rather uniform penetration of the entire brain by the drug. A maximum of 43 per cent of the tissue radioactivity was found in the cerebellum 2 h after i.p. injection, while 49 per cent accumulated in the extracortical portion of the brain 3·5 h after i.th. administration. Methionine did not affect the regional distribution of [ 3 H]MSO. (3) Differential centrifugation of samples of cortex and cerebellum revealed an association of [ 3 H]MSO with intracellular particulate fractions. Since closely similar proportions of MSO occurred in the crude mitochondrial and the microsomal fractions, these fractions were analysed further: (a) [ 3 H]MSO was bound to nerve endings sedimenting at the 1·0 m–1·2 m-sucrose interface; this binding was not abolished by prior increase of the endogenous cerebral methionine pool; and (b) [ 3 H]MSO was released by subjecting the nerve endings to osmotic shock. However, the striking finding was that [ 3 H]MSO could not be released from the nerve endings of the cerebellum from animals pre-treated with methionine. (4) An association of [ 3 H]MSO was observed with the membranes of the endoplasmic reticulum and specifically with its agranular component. (5)The results implicate the cerebellum as the primary target for MSO, in confirmation of the original observations of Lodin (1958).en_US
dc.format.extent898788 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1970 International Society for Neurochemistryen_US
dc.titleTHE EFFECT OF METHIONINE ON THE REGIONAL AND INTRACELLULAR DISPOSITION OF [ 3 H]-METHIONINE SULPHOXIMINE IN RAT BRAIN 1en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan Medical Center, Ann Arbor, Michigan 48104en_US
dc.identifier.pmid5426666en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65357/1/j.1471-4159.1970.tb02259.x.pdf
dc.identifier.doi10.1111/j.1471-4159.1970.tb02259.xen_US
dc.identifier.sourceJournal of Neurochemistryen_US
dc.identifier.citedreferenceAzcurra J. M. and Sellinger O. Z. ( 1967 ) Brain Res. 6, 359.en_US
dc.identifier.citedreferenceCampagnoni A. T. and Mahler H. R. ( 1967 ) Biochemistry, Easton 6, 956.en_US
dc.identifier.citedreferenceDallner G. ( 1963 ) Acta pathol. microbiol. scand., Suppl. 166.en_US
dc.identifier.citedreferenceDaniel R. G. and Waisman H. A. ( 1969 ) J. Neurochem. 16, 787.en_US
dc.identifier.citedreferenceDel Cerro M. P., Snider R. S. and Oster M. L. ( 1969 ) Exp. Brain Res. 8, 311.en_US
dc.identifier.citedreferenceDe Robertis E., Pellegrino de Iraldi A., Rodriguez de Lores Arnaiz G. and Salganicoff L. ( 1962 ) J. Neurochem. 9, 23.en_US
dc.identifier.citedreferenceDe Robertis E., Rodrfguez de Lores Arnaiz G., Salganicoff L., Pellegrino de Iraldi A. and Zieher L. M. ( 1963 ) J. Neurochem. 10, 225.en_US
dc.identifier.citedreferenceDe Robertis E., Sellinger O. Z., Rodriguez de Lores Arnaiz G., Alberici M. and Zieher L. M. ( 1967 ) J. Neurochem. 14, 81.en_US
dc.identifier.citedreferenceFleck A. and Begg D. ( 1965 ) Biochim. biophys. Acta 108, 333.en_US
dc.identifier.citedreferenceFolbergrovÁ J. ( 1964 ) Physiol. bohemoslov. 13, 21.en_US
dc.identifier.citedreferenceFolbergrovÁ J., Passonneau J., Lowry O. H. and Schulz D. W. ( 1969 ) J. Neurochem. 16, 191.en_US
dc.identifier.citedreferenceJohnson, Goldring and O'Leary ( 1965 ) Electroencephal. Clin. Neurophysiol. 18, 229.en_US
dc.identifier.citedreferenceLamar C. Jr. ( 1968 ) Biochem. Pharmacol. 17, 636.en_US
dc.identifier.citedreferenceLamar C. Jr. and Sellinger O. Z. ( 1965 ) Biochem. Pharmacol. 14, 489.en_US
dc.identifier.citedreferenceLodin Z. ( 1958 ) Physiol. bohemoslov. 7, 95.en_US
dc.identifier.citedreferenceLodin Z., Faltin J., Pilny J. and Hartman J. ( 1968 ) Physiol. bohemoslov. 17, 527.en_US
dc.identifier.citedreferenceLodin Z., Hartman J., Faltin J. and Malanowski J. ( 1968 ) Physiol. bohemoslov. 17, 417.en_US
dc.identifier.citedreferenceLodin Z. and Kolousek J. ( 1958a ) Physiol. bohemoslov. 7, 87.en_US
dc.identifier.citedreferenceLodin Z. and Kolousek J. ( 1958b ) Physiol. bohemoslov. 7, 292.en_US
dc.identifier.citedreferenceLodin Z., Muller J. and Faltin J. ( 1968 ) Physiol. bohemoslov. 7, 317.en_US
dc.identifier.citedreferenceLowry O. H., Rosebrough N. J., Farr A. L. and Randall R. S. ( 1951 ) J. biol. Chem. 193, 265.en_US
dc.identifier.citedreferenceMurty C. N. and Hallinan T. ( 1969 ) Biochem. J. 112, 269.en_US
dc.identifier.citedreferencePeters E. L. and Tower D. B. ( 1959 ) J. Neurochem. 5, 80.en_US
dc.identifier.citedreferenceProler M. and Kellaway P. ( 1965 ) Neurology, Minneap. 15, 931.en_US
dc.identifier.citedreferenceProler M. and Kellaway P. ( 1962 ) Epilepsia, 3, 117.en_US
dc.identifier.citedreferenceReiner L., Misani F. and Weiss P. ( 1950 ) Archs. Biochem. Biophys. 25, 447.en_US
dc.identifier.citedreferenceSellinger O. Z. ( 1967 ) Biochim. biophys. Acta 132, 514.en_US
dc.identifier.citedreferenceSellinger O. Z. and Azcurra J. M. ( 1968 ) In Macromolecules and the Function of the Neuron ( Edited by Lodin Z. and Rose S. P. R. ) p. 256. Excerpta Medica Press, Amsterdam.en_US
dc.identifier.citedreferenceSellinger O. Z. and Azcurra J. M. ( 1970 ) In Protein Metabolism of the Nervous System ( Edited by Lajtha A. ) Chapter 25, Plenum Press, New York.en_US
dc.identifier.citedreferenceSellinger O. Z., Azcurra J. M. and Ohlsson W. G. ( 1968 ) J. Pharmac. exp. Ther. 164, 212.en_US
dc.identifier.citedreferenceSellinger O. Z. and De Balbian Verster F. ( 1962 ) J. biol. Chem. 237, 2836.en_US
dc.identifier.citedreferenceSellinger O. Z., De Balbian Verster, F., Sullivan R. J. and Lamar C. Jr. ( 1966 ) J. Neurochem. 13, 501.en_US
dc.identifier.citedreferenceSellinger O. Z. and Domer F. R. ( 1964 ) Experientia 20, 686.en_US
dc.identifier.citedreferenceSellinger O. Z., Domino E. F., Haarstad V. B. and Mohrmann M. ( 1969 ) J. Pharmac. exp. Ther. 167, 63.en_US
dc.identifier.citedreferenceSellinger O. Z. and Nordrum L. M. ( 1969 ) J. Neurochem. 16, 1219.en_US
dc.identifier.citedreferenceSellinger O. Z. and Ohlsson W. G. ( 1969a ) J. Neurochem. 16, 1193.en_US
dc.identifier.citedreferenceSellinger O. Z. and Ohlsson W. G. ( 1969b ) Life Sci. 8, 1083.en_US
dc.identifier.citedreferenceSellinger O. Z. and Weiler P. G. Jr. ( 1963 ) Biochem. Pharmacol. 12, 989.en_US
dc.identifier.citedreferenceShah N. S., Kamano A., Glisson S. and Callison D. ( 1968 ) Int. J. Neuropharmacol. 7, 75.en_US
dc.identifier.citedreferenceTower D. B. ( 1960 ) Neurochemistry of Epilepsy Thomas, Springfield, Illinois.en_US
dc.identifier.citedreferenceWolfe L. S. and Elliot K. A. C. ( 1962 ) In Neurochemistry ( Edited by Elliot K. A. C., Page I. H. and Quastel J. H. ) 2nd ed., p. 694. Thomas, Springfield, Illinois.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.